<DOC>
	<DOCNO>NCT02152657</DOCNO>
	<brief_summary>The purpose study analyze safety efficacy mesenchymal stem cell transplantation percutaneous injection patient chronic spinal cord injury .</brief_summary>
	<brief_title>Evaluation Autologous Mesenchymal Stem Cell Transplantation Chronic Spinal Cord Injury : Pilot Study</brief_title>
	<detailed_description>This pilot , open , phase I study , prospective cohort . The study population consist 5 patient spinal cord injury least 6 month , complete paraplegia . A practitioner , neurosurgeon nurse review medical record patient determine presence / absence inclusion / exclusion criterion . If patient potential candidate study , interview schedule patient review confirm his/her eligibility . If clinical eligibility confirm , patient undergo psychosocial evaluation determine degree emotional equilibrium condition participation study . Patients undergo series clinical neurological evaluation also submit follow procedure : - Cell blood count ; - Biochemical analysis ( measurement electrolytes - sodium , potassium , magnesium ) ; - Renal function test ( urea creatinine ) ; - Liver function test ; - Coagulation profile ; - Metabolic profile ( glucose , total cholesterol fraction ) ; - Urine summary culture ; - Serology require blood transfusion marrow transplant Brasil ; - Electrocardiogram ; - Chest X-Ray , X-ray knee ; - Bone densitometry ; - Urodynamic study ; - Somatosensory evoked potential ; - Computed tomography thoracic lumbar spine ; - MRI thoracic lumbar spine . Also part preoperative evaluation , patient respond question SF ( Short Form ) -36 questionnaire ( assessment quality life ) questionnaires assessment neuropathic pain . Clinical follow-up kept patient suspend participation study adverse event / laboratory abnormality , patient 's desire , follow insurance protocol . In addition clinical surgical follow-up , specific medical care offer patient experience adverse event , stabilization patient , even target date completion study exceed . The candidate include study ask voluntarily participate give inform write consent . Patients recruit minimum period 06 month follow additional laboratory clinical examination .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Closed spinal cord injury thoracic thoracolumbar level bellow T8 , open spinal cord injury , level , provide mechanism lesion spinal shock , ischemia hematoma ASIA class A Signing write consent Anatomical transection spinal cord Spinal cord lesion sharp object Ongoing infection Terminal , neurodegenerative primary hematological disease Osteopathies determine high risc bone marrow puncture Coagulopathies Severe hepatic , renal heart failure Pregnancy lactation Clinical condition hinder percutaneous injection cell arthrodesis Use metallic implant near vascular structure ( cardiac pacemaker aortic prosthesis ) wo n't allow patient perform MRI Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Spinal cord injury</keyword>
	<keyword>Stem cell transplantation</keyword>
	<keyword>Mesenchymal stem cell</keyword>
</DOC>